Hims & Hers Health (HIMS) reported Q1 earnings Monday of $0.20 per diluted share, up from $0.05 a year earlier.
Analysts polled by FactSet expected $0.12.
Revenue for the quarter ended March 31 was $586.0 million, up from $278.2 million a year earlier.
Analysts surveyed by FactSet expected $538.6 million.
Gross margin was 73% for Q1, compared with 82% a year ago.
The company said it expects Q2 revenue of $530 million to $550 million. Analysts expected $564.6 million.
The company reiterated 2025 revenue guidance of $2.3 billion to $2.4 billion. Analysts expected $2.33 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.